Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anlin Li

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Science Bulletin|November 27, 2025
Urbanization accelerates lake warming: evidence from ChinaAnlin Li, Yi Luo, Kun Yang, et al.
International Journal of Biological Macromolecules|August 27, 2025
Aucubin-loaded BSAMA/GelMA hydrogel accelerates diabetic wound healing via ROS scavengingZhixiang Mu, Yan Yang, Guanyao Zhang, et al.
Clinical and Translational Medicine|June 9, 2020
Joint association of patients' sex and PD-L1 expression with overall survival benefits and tumor-immune microenvironment in immune checkpoint inhibitors for cancersAnlin Li, Yongjian Chen, Wenda Zhang, et al.
NPJ Precision Oncology|September 11, 2023
Deciphering transcriptomic determinants of the divergent link between PD-L1 and immunotherapy efficacyAnlin Li, Linfeng Luo, Wei Du, et al.
Clinical and Translational Medicine|June 9, 2020
Novel blood-based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non-small-cell lung cancer: Results from two multicenter, randomized clinical trialsYunfang Yu, Yongjian Chen, Anlin Li, et al.
Annals of Translational Medicine|April 21, 2020
Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinomaQiyun Ou, Yunfang Yu, Anlin Li, et al.
JMIR Formative Research|September 23, 2025
Surveillance of Twitter Data on COVID-19 Symptoms During the Omicron Variant Period: A Sentiment AnalysisKaiyue Zhang, Zhaojin Guo, Yujie Ai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 26, 2023
STK11/LKB1-Deficient Phenotype Rather Than Mutation Diminishes Immunotherapy Efficacy and Represents STING/Type I Interferon/CD8<sup>+</sup> T-Cell Dysfunction in NSCLCAnlin Li, Yuanyuan Wang, Zhixin Yu, et al.
Therapeutic Advances in Medical Oncology|October 26, 2023
Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitorLi-Na He, Tao Chen, Sha Fu, et al.
Ebiomedicine|July 7, 2021
Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter studyYunfang Yu, Zifan He, Jie Ouyang, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Science Bulletin|November 27, 2025
Urbanization accelerates lake warming: evidence from ChinaAnlin Li, Yi Luo, Kun Yang, et al.
International Journal of Biological Macromolecules|August 27, 2025
Aucubin-loaded BSAMA/GelMA hydrogel accelerates diabetic wound healing via ROS scavengingZhixiang Mu, Yan Yang, Guanyao Zhang, et al.
Clinical and Translational Medicine|June 9, 2020
Joint association of patients' sex and PD-L1 expression with overall survival benefits and tumor-immune microenvironment in immune checkpoint inhibitors for cancersAnlin Li, Yongjian Chen, Wenda Zhang, et al.
NPJ Precision Oncology|September 11, 2023
Deciphering transcriptomic determinants of the divergent link between PD-L1 and immunotherapy efficacyAnlin Li, Linfeng Luo, Wei Du, et al.
Clinical and Translational Medicine|June 9, 2020
Novel blood-based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non-small-cell lung cancer: Results from two multicenter, randomized clinical trialsYunfang Yu, Yongjian Chen, Anlin Li, et al.
Annals of Translational Medicine|April 21, 2020
Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinomaQiyun Ou, Yunfang Yu, Anlin Li, et al.
JMIR Formative Research|September 23, 2025
Surveillance of Twitter Data on COVID-19 Symptoms During the Omicron Variant Period: A Sentiment AnalysisKaiyue Zhang, Zhaojin Guo, Yujie Ai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 26, 2023
STK11/LKB1-Deficient Phenotype Rather Than Mutation Diminishes Immunotherapy Efficacy and Represents STING/Type I Interferon/CD8<sup>+</sup> T-Cell Dysfunction in NSCLCAnlin Li, Yuanyuan Wang, Zhixin Yu, et al.
Therapeutic Advances in Medical Oncology|October 26, 2023
Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitorLi-Na He, Tao Chen, Sha Fu, et al.
Ebiomedicine|July 7, 2021
Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter studyYunfang Yu, Zifan He, Jie Ouyang, et al.
Pageof 4